CHRONIC NEUROLOGY + PSYCHIATRY
YEAR 2 | PAGE 26F - MOVEMENT, DEMYELINATION, NMJ, MOOD, PSYCHOSIS + PHARM
NEUROPSYCHIATRY INTEGRATION NEURO: pattern + localization + tempo -> mechanism -> confirmatory test -> disease-modifying/symptomatic therapy. PSYCH: syndrome + duration +
functional impairment + substances/medical causes -> safety -> diagnosis -> therapy. Medication questions require mechanism, signature adverse effect and the syndrome the drug can mimic.
1
| Multiple Sclerosis - Ninja Nerd | ~54 min |
|---|---|
| Immune-mediated CNS demyelination, optic neuritis/INO and other localizing findings, MRI/CSF diagnosis, relapse treatment and disease-modifying therapy. |
2
| Parkinson's Disease Drugs - Ninja Nerd | ~1 hr 37 |
|---|---|
| Basal ganglia direct/indirect pathways plus levodopa, dopamine agonists, COMT/MAO-B inhibitors, amantadine and anticholinergic mechanisms/adverse effects. |
3
| Drugs for Epilepsy - Ninja Nerd | ~1 hr 07 |
|---|---|
| Mechanism-first antiepileptic pharmacology, seizure-type selection, major toxicities, teratogenicity and practice questions. |
4
| Top NBME Concepts - Psychiatry (Step 1) - HyGuru | ~1 hr 10 |
|---|---|
| Integrated review of mood disorders, grief vs depression, mania/lithium, psychotic disorders, eating disorders and substance-use/toxicology patterns. |
5
| Anxiolytic & Hypnotic Drugs - Ninja Nerd | ~1 hr 09 |
|---|---|
| Anxiety/insomnia pathophysiology plus benzodiazepines, Z-drugs, barbiturates, buspirone and related safety/adverse-effect reasoning. |
6
| Dopamine Pathways, Antipsychotics + EPS - Dirty Medicine | targeted |
|---|---|
| High-yield mesolimbic/mesocortical/nigrostriatal/tuberoinfundibular pathways; ties antipsychotic action to EPS and endocrine adverse effects. |
6 — PSYCHIATRY DIFFERENTIATION CHECK
- Use time course + functional impairment to separate normal stress/grief from mood/anxiety disorders; screen substance/medication/medical causes before assuming primary psychiatry.
- For psychosis, separate schizophrenia-spectrum disorders from mood disorders with psychotic features, delirium, substance-induced states and neurologic disease.
- Know medication emergencies: serotonin syndrome, NMS, lithium toxicity, valproate/carbamazepine toxicity, benzodiazepine withdrawal and severe antipsychotic metabolic/EPS effects.